EVALUATION OF STATISTICAL METHODS FOR ANALYSIS OF SMALL-SAMPLE LONGITUDINAL CLINICAL TRIALS WITH DROPOUTS
スポンサーリンク
概要
- 論文の詳細を見る
In longitudinal clinical trials that compare treatments of chronic diseases missing data occur mainly because of dropouts, where patients stop participating in the trial before the completion due to various reasons. Such incomplete data are often analyzed by using so-called completer analysis and/or LOCF (Last Observation Carried Forward). However, such procedures require strong assumptions for their validity. Multiple imputation (MI) (Rubin, 1987) is a valid method under MAR (Missing At Random). This method consists of three steps ("imputation", "analysis" and "combination") and various methods for MI also have been proposed. In this paper, we evaluate the performance of four methods for MI contrasted with completer analysis and LOCF via Monte-Carlo simulations in the context of small-sample longitudinal clinical trials for comparison of two treatments. The performance of these methods with non-normal data (i.e. mixture of responders and non-responders) is also examined.
- 日本計算機統計学会の論文
著者
-
Abe Takayuki
Biostatistics & Research Decision Sciences Banyu Pharmaceutical Co. Ltd.
-
Iwasaki Manabu
Department of Computer and Information Science, Seikei University
-
Iwasaki Manabu
Seikei Univ. Tokyo Jpn
-
Iwasaki Manabu
Department Of Computer And Information Science Faculty Of Science And Engineering Seikei University
関連論文
- EVALUATION OF STATISTICAL METHODS FOR ANALYSIS OF SMALL-SAMPLE LONGITUDINAL CLINICAL TRIALS WITH DROPOUTS
- Pretreatment prediction of response to peginterferon plus ribavirin therapy in genotype 1 chronic hepatitis C using data mining analysis
- A Practical Method for Determining Minimum Detectable Values in Pulse-Counting Measurements
- ASSESSMENT OF NON-NORMALITY IN PRETEST-POSTTEST RESEARCH UNDER SCREENING OF THE PRETEST SCORE
- Notes on the Central and Shortest Confidence Intervals for a Binomial Parameter
- Pretreatment prediction of anemia progression by pegylated interferon alpha-2b plus ribavirin combination therapy in chronic hepatitis C infection : decision-tree analysis
- SAMPLE SIZE DETERMINATION BASED ON MID-P VALUE FOR USE WITH THE TESTING IN 2×2 COMPARATIVE TRIALS : To the memory of the late Professor Kazumasa Wakimoto
- Less Conservative Distribution-free Confidence Intervals and Tests for the Median
- Analysis of correlated binary data with missing(Session 4b)
- Darbepoetin alfa (KRN321) is safe and effective when administered subcutaneously once every 2 or 4 weeks to patients on peritoneal dialysis in Japan
- DETERMINATION OF SAMPLE SIZES FOR USE IN CONSTRUCTING CONFIDENCE INTERVALS : FOR A BINOMIAL PARAMETER